Home
> Uncategorized > Senseonics nets $20M, starts trials for connected, embedded continuous glucose monitor
Senseonics nets $20M, starts trials for connected, embedded continuous glucose monitor
Germantown, Maryland-based continuous glucose monitor developer Senseonics raised $20 million from existing investors Anthem Capital, Delphi Ventures, Greenspring Associates, Healthcare Ventures, and New Enterprise Associates.
Categories: Uncategorized
Exponential Medicine
Comments (0)
Trackbacks (0)
Leave a comment
Trackback